Insider buying last 90 days
No open-market insider purchases were filed for MDT in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every MDT insider filing, plotted on the chart in Gekko.Open MDT in Gekko
NYSE: MDT
Medtronic (MDT) Stock Analysis & Forecast
$92.13−0.64 (−0.7%)
Close on Sep 18, 2026. Page updated Sep 19, 9:16 pm ET.
Gekko Brief
AI summaryMedtronic closes at $92.13, down 0.7%, with the stock above both its 50-day average of $88.70 and its 200-day average of $89.26. The GekkoIndex reads 56.8, placing MDT in the Neutral zone, while the price sits 24.7% below the Gekko Fair Value of $122.37.
The week's news centers on cardiovascular momentum and robotic surgery progress. Medtronic raised its fiscal 2027 profit and revenue outlook for the second time, citing strong cardiovascular device demand and double-digit growth across major segments, following quarterly earnings of $1.45 per share on $9.76 billion in revenue that beat estimates. Separately, the FDA cleared Medtronic's LigaSure vessel-sealing technology and its LigaSure RAS Maryland jaw device for use with the Hugo robotic-assisted surgery system, extending capabilities already available in Europe into U.S. urologic procedures. Medtronic also named Lara Barghout, former CEO of Recor Medical, as president of its Interventional Cardiology Therapies unit. Separately, an EVP sold 1,483 shares for $138,882.95, reducing his stake by 3.4% to 42,186 shares.
Medtronic's next earnings report is scheduled for 17 November 2026, before the open, 58 days out and beyond a typical 20-trading-day hold. Options activity shows one unusual signal in the last 30 days, with call premium of $2,502,266 against put premium of $343,809. Seasonally, the next 20 trading days have averaged a decline of 4.6% over five years, rising in two of them. Analyst coverage includes 12 buy and 8 hold ratings among 20 firms, with a consensus target of $104.83.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Price vs fair value
Close $92.13200-day averageGekko Fair Value $122.37
Key stats
- Market cap
- $117.9B
- P/E ratio
- 22.9
- Forward P/E
- 15.5
- EPS, TTM
- $4.06
- Revenue, TTM
- $37.54B
- Profit margin
- 13.9%
- Dividend yield
- 3.08%
- Beta
- 0.57
- Volume
- 13.62M avg 8.34M
- 1-year return
- −2.6%
- Typical daily move
- ±2.5%
- Typical 20-day move
- ±4.4%
- 50-day average
- $88.70
- 200-day average
- $89.26
- Next earnings
- Nov 17 before open
- Shares outstanding
- 1.28B
Medtronic swing-trade checklist
Medtronic scores 3 supportive, 2 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed1 headwind
- Trendmixed
Averages disagree
Close $92.13 sits between the 50-day ($88.70) and 200-day ($89.26) averages, or the averages disagree.
See the chart - GekkoIndexmixed
56.8, Neutral
Reading 56.8 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
24.7% below
Price is 24.7% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneysupportive
Leans bullish
Last 30 days: 1 unusual options signal.
See smart money - Earnings risksupportive
Reports in 58 days
Next report Nov 17, 2026, 58 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−4.6% on average
From this point in the calendar, the next 20 trading days averaged −4.6% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Medtronic stock chart and price history
Medtronic closed at $92.13 on Sep 18, 2026, −2.6% over the past year, inside a 52-week range of $73.31 to $106.33.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −2.1%
- 3 months
- +16.1%
- 6 months
- +6.1%
- 1 year
- −2.6%
The full MDT chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open MDT in Gekko
Follow Medtronic through every session
Put MDT on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track MDT in GekkoFree for 7 days. No credit card required.
About Medtronic
Medtronic designs, manufactures and supplies device-based medical therapies used by hospitals, clinicians and patients worldwide. Its work is best known in areas such as heart rhythm devices, surgical tools and diabetes management technology, covering everything from implantable pacemakers to insulin pumps.
The company organizes its work into several portfolios. One covers cardiovascular care, including devices for heart rhythm, structural heart repair and coronary procedures. Another supplies surgical instruments, robotic-assisted platforms and equipment for areas such as hernia repair, lung treatment and patient monitoring. A further portfolio serves specialists like neurosurgeons and pain management doctors with imaging and spinal guidance tools, while a separate unit focuses on diabetes care, offering insulin pumps, glucose monitors and connected insulin pens. Customers span healthcare systems, physicians and patients across many medical fields.
Founded in 1949, Medtronic is headquartered in Dublin, Ireland. Its shares are listed on the NYSE under the ticker MDT.
- Listed
- NYSE
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- medtronic.com
Medtronic GekkoIndex: the smart money zone
Medtronic’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 56.8, in the Neutral zone, down 0.9 points over five sessions.
56.8Neutral
Down 0.9 points over five sessions.
Reading for Sep 18, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 33 | +0.8% | +4.3% | ||
| Accumulation | 233 | 0.0% | +0.1% | ||
| Neutral (current zone) | 376 | +0.1% | +0.3% | ||
| Distribution | 19 | −0.5% | −2.6% | ||
| Selling | 1 | Too few readings yet | |||
Average MDT share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.2% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the MDT price, zone by zone.Track MDT in Gekko
Is Medtronic stock overvalued? Gekko Fair Value
Medtronic trades 24.7% below Gekko Fair Value of $122.37, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Medtronic shares are worth, recalculated every trading day.
$122.37
Gekko Fair Value, Sep 19, 2026
24.7% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open MDT in Gekko
Medtronic insider and Congress trading
No open-market insider purchases were filed for Medtronic, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in MDT were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for MDT, plotted on the chart in Gekko.Open MDT in Gekko
Buybacks
Medtronic has been buying back its own shares.
- Bought back, quarter ended Jul 31, 2026
- $267.0M
- As a share of market cap
- 0.23%
- Trailing four quarters
- $1.18B
From company filings.
Unusual options activity last 30 days
1signal, 88% of the flagged premium in calls.
Latest: Bullish flow on Sep 2, $2.85M in unusual premium.
Hedge funds and billionaires quarter ended Mar 31
0of the funds Gekko tracks hold MDT.
0added0opened0trimmed1sold out
Every signal with its contract, strike and premium, and which funds are on each side.Unlock in Gekko
Medtronic earnings: next date and track record
Medtronic reports on Nov 17, 2026, before the open (58 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Nov 17, 2026
Expected before the open, 58 days away
- EPS estimate
- $1.34
- Revenue estimate
- $9.48B
7 of 8reports beat the EPS estimate
±4.6%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 18, 2026 | $1.45 est $1.39 | — | +3.9% |
| Jun 3, 2026 | $1.55 est $1.56 | $9.81B est $9.62B | +11.1% |
| Feb 17, 2026 | $1.36 est $1.33 | — | −1.0% |
| Nov 18, 2025 | $1.36 est $1.31 | $8.96B est $8.87B | +4.2% |
| Aug 19, 2025 | $1.26 est $1.23 | $8.58B est $8.38B | +0.4% |
| May 21, 2025 | $1.62 est $1.58 | $8.93B est $8.82B | −6.3% |
| Feb 18, 2025 | $1.39 est $1.36 | $8.29B est $8.33B | −6.3% |
| Nov 19, 2024 | $1.26 est $1.25 | $8.40B est $8.27B | −4.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Medtronic stock forecast and analyst price targets
Analysts’ average 12-month price target for Medtronic is $104.83, +13.8% from the last close, from 20 firms rating the stock in the last 90 days.
$104.83consensus 12-month target, +13.8% from the last close
Now $92.13Avg $104.83
Low $85High $118
Each firm’s latest rating in the last 90 days: 20 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 17 | Needham | $114 | +23.7% |
| Sep 15 | TD Cowen | $110 | +19.4% |
| Sep 14 | Bank of America Securities | $110 | +19.4% |
| Sep 10 | Citi | $110 | +19.4% |
| Sep 10 | William Blair | — | — |
+0.3%average 20-day move after past Neutral readings
−4.6%average move over the next 20 trading days in the last 5 years
±2.5%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Medtronic seasonality: the next 20 trading days
Over the next 20 trading days from Sep 19, Medtronic averaged −4.6% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −2.6% | 2 of 5 |
| Next 10 trading days | −2.8% | 2 of 5 |
| Next 15 trading days | −4.0% | 2 of 5 |
| Next 20 trading days | −4.6% | 2 of 5 |
| Next 30 trading days | −5.1% | 1 of 5 |
For scale, MDT’s typical 20-trading-day move in either direction is about 4.4%.
Medtronic market cap and key statistics
Medtronic’s market cap is $117.9B, with a P/E ratio of 22.9 and revenue of $37.54B over the last twelve months.
Valuation
- Market cap
- $117.9B
- P/E ratio
- 22.9
- Forward P/E
- 15.5
- EPS, TTM
- $4.06
- Gekko Fair Value
- $122.37
Trading
- Volume
- 13.62M
- Avg volume, 20 days
- 8.34M
- 52-week high
- $106.33
- 52-week low
- $73.31
- Shares outstanding
- 1.28B
Financials
- Revenue, TTM
- $37.54B
- Profit margin
- 13.9%
- Return on equity
- 10.6%
- Quarterly earnings growth, YoY
- +40.7%
Risk and income
- Beta
- 0.57
- Typical daily move
- ±2.5%
- Typical 20-day move
- ±4.4%
- Dividend yield
- 3.08%
Medtronic stock news this week
Coverage of Medtronic this week reads positive: 18 positive, 1 neutral and 0 negative headlines.
- Harry Skip Kiil Sells 1,483 Shares of Medtronic (NYSE:MDT) StockMarketBeat, Sep 17
- Medtronic Raises Guidance Again as Heart Device Demand SurgesMedical Device and Diagnostic industry, Sep 17
- Should You Buy Medtronic Stock as Its Hugo Surgical Robot Gains Ground?The Motley Fool, Sep 17
- FDA clears vessel-sealing device for Medtronic’s Hugo robotMedTech Dive, Sep 17
- FDA clears Medtronic’s LigaSure RAS Maryland deviceMedical Device Network, Sep 17
- BSX vs. MDT: Which Electrophysiology Stock Is the Better Bet Now?Zacks Investment Research, Sep 17
Medtronic peers
Medtronic’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Distribution | 17.1% above |
| ABTAbbott Laboratories | Accumulation | 15.5% below |
| DHRDanaher | Neutral | 1.1% above |
| ISRGIntuitive Surgical | Neutral | 12.3% above |
| SYKStryker | Buying | 17.1% below |
| BSXBoston Scientific | Accumulation | 35.9% below |
A peer links to its own page where one exists.
Medtronic stock FAQ
What is Medtronic’s market cap?
Medtronic’s market cap is $117.9B at the Sep 18, 2026 close of $92.13, with 1.28B shares outstanding. The shares trade on a P/E ratio of 22.9.
What is the Medtronic stock forecast?
The consensus analyst 12-month price target for Medtronic is $104.83, +13.8% from the last close. Of the 20 firms that rated the stock in the last 90 days, 12 rate it a buy, 8 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Medtronic stock overvalued or undervalued?
On Gekko’s estimate Medtronic is undervalued: the Sep 18, 2026 close of $92.13 is 24.7% below Gekko Fair Value of $122.37. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Medtronic report earnings next?
Medtronic is expected to report on Nov 17, 2026, before the market opens (58 days away). Analysts expect earnings of $1.34 per share on revenue of $9.48B. Medtronic beat the earnings estimate in 7 of its last 8 reports, moving 4.6% on average across the report.
What is Medtronic’s 52-week high and low?
Medtronic’s 52-week high is $106.33 and its 52-week low is $73.31; it closed at $92.13 on Sep 18, 2026, −2.6% over the past year.
Is Medtronic stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (fair value, smart money and earnings risk), 2 as mixed (trend and gekkoindex) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
Is there unusual options activity in Medtronic?
Gekko flagged 1 unusual options signal in Medtronic over the last 30 days, with $2.50M of flagged premium in calls and $344K in puts. The latest, bullish flow, was on Sep 2, 2026 with $2.85M in unusual premium. The signal-by-signal table is in Gekko.
How this page works
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Medtronic the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.